Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically underserved patients

Summer Undergraduate Research Training Program, College of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Ethnicity & disease (Impact Factor: 1). 12/2005; 15(1):25-32.
Source: PubMed


Hypertension is a major contributor to ethnic disparities in cardiovascular disease, especially among low-income African Americans in the southeast United States.
To assess differences between African Americans and Caucasians in the prevalence, treatment, and control of hypertension in outpatient clinics for under-served patients in South Carolina.
A random sample of outpatient charts on 7795 adults was abstracted from 31 primary care clinics providing health care for approximately 180,000 medically under-served patients. Variables included visit dates, blood pressures (BP), diagnosis of hypertension, and medications.
Data were abstracted from outpatient medical records on 4694 African Americans (1483 men, 3195 women, 16 gender unknown, age 46.8 +/- 0.3 years) and 2540 Caucasians (1031 men, 1492 women, 17 gender unknown, age 47.7 +/- 0.4 years). The prevalence of hypertension was greater in African Americans than Caucasians (47.6% vs 31.0%, P < .001). The percentages of hypertensive African Americans and Caucasians receiving BP medications were similar (83.4% vs 81.6%, P=NS). Although African-American hypertensives were more likely than Caucasian hypertensives to receive diuretics and calcium channel blockers and less likely to receive beta-blockers, the number of BP medications was similar for both groups (1.44 +/- 0.02 vs 1.40 +/- 0.04, P=NS). Despite comparable treatment, African Americans were less likely than Caucasians to have BP controlled to <140/90 mm Hg at the most recent clinic visit (40.9% vs 46.3%, P=.01).
In healthcare settings for medically under-served patients, the greater prevalence and lesser control of hypertension, despite similar treatment intensity, may contribute to higher rates of cardiovascular disease among African Americans than Caucasians.

Download full-text


Available from: Brent Egan,
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Despite evidence of decreased cardiovascular disease morbidity and mortality, control of blood pressure is largely suboptimal especially in urban settings. Evaluation of predictors of blood pressure control in these settings is exceedingly important in order to develop strategies for improved outcomes. Methods: We surveyed 259 African-American patients with essential hypertension in an urban primary care setting. Patients were divided into two groups, based on whether blood pressure was controlled, below 140/90 mmHg (n = 181; 70%) or uncontrolled, above 140/90 mmHg (n = 78; 30%). Predictors of blood pressure control were determined using multivariable logistic regression. Results: There were no differences between the two groups in mean age, body mass index or gender. Controlled as compared with uncontrolled patients had a significantly higher percentage of reporting regular exercise (p = 0.01), lower rate of blood pressure medication nonadherence (p = 0.03), were less likely to be prescribed calcium channel blockers (p = 0.01), lower rate of total serum cholesterol (<240 mg/dl; p = 0.03) and lower serum creatinine (p = 0.04). All other factors were similar between the two groups. The odds ratio (OR) of uncontrolled blood pressure was associated with lack of regular exercise (OR: 2.26; 95% confidence interval [CI]: 1.16-4.37; p = 0.02), use of calcium channel blockers (OR 2.30; 95% CI: 1.22-4.32; p = 0.01), total cholesterol greater than 240 mg/dl (OR: 3.10; 95% CI: 1.36-7.00; p = 0.01), and blood pressure medication nonadherence (OR: 1.96; 95% CI: 1.02-3.74, p = 0.01). Conclusion: These data form a basis, and indicate the need for focused interventions to control blood pressure in urban primary care settings.
    Therapy 11/2005; 2(6):901-907. DOI:10.2217/14750708.2.6.901
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Medication choices for the treatment of elevated blood pressure have a large potential impact on both patient outcomes and health care costs. Historic trends of prescribing for hypertension will advance the understanding of physician practice of evidence-based medicine. This study describes both long- and short-term trends in US antihypertensive prescribing from 1990 through 2004. Data were extracted from the National Disease and Therapeutic Index, a continuing survey of a national sample of US office-based physicians. Cox and Stuart and z tests were performed. Diuretics ranked among the top 3 antihypertensive drug classes throughout the entire study time span. Angiotensin-converting enzyme (ACE) inhibitors and calcium channel blockers (CCBs) were preferred over diuretics beginning in 1993, with diuretics surpassing CCBs in 2000. Beta-blockers were consistently the fourth most common class until 2002, when exceeded by angiotensin II receptor antagonists (ARBs). Most recent trends indicated an immediate but short-lived increase in the prescription of thiazide diuretics after the new clinical evidence released in December 2002 demonstrating clinical equivalence of thiazides to ACE inhibitors and CCBs. In contrast, prescription of ACE inhibitors declined, accompanied by continuation of a pre-existing increase in the prescription of ARBs, whereas prescription of CCBs remained essentially stable after the new evidence was released. The recorded long- and short-term trends indicate that evidence-based clinical recommendations had an impact on antihypertensive prescribing practices, but the magnitude of impact may be smaller and of more limited duration than desired.
    Hypertension 09/2006; 48(2):213-8. DOI:10.1161/01.HYP.0000229653.73128.b6 · 6.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The prevalence of hypertension dictates that blood pressure must be managed effectively in primary care. The American Society of Hypertension (ASH) regional chapters and clinical hypertension specialists represent a positive response by ASH to the growing problems of hypertension and metabolic syndrome-related risks and disease. To have a significant public health effect, the impact of clinical hypertension specialists must be leveraged. Key activities in the community include educating other providers locally, delivering care for complex referral patients, and fostering growth of a practice network with a central database in collaboration with academic partners. The database supports practice audit and feedback reports to enhance quality improvement, identify continuing medical education topics, and facilitate clinical trials to test new therapeutic and best-practice approaches to risk factor management. The ASH regional chapters serve as a forum for community and academic hypertension specialists to collaborate with like-minded individuals and organizations. The collaboration among the ASH Carolinas-Georgia chapter, the Hypertension Initiative, and the Community Physicians' Network provides a model for other ASH chapters and health delivery groups to partner in delivering continuing medical education programs focused on cardiovascular risk factor management, recruiting practices into the network, and developing and maintaining a centralized patient database. Evidence suggests that this collaboration is facilitating application of evidence-based medicine and risk factor control.
    Journal of Clinical Hypertension 01/2007; 8(12):879-86. DOI:10.1111/j.1524-6175.2006.05677.x · 2.85 Impact Factor
Show more